[XENE] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
07-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -107.75%
YoY- -5.70%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 2,218 13,384 0 0 15 413 4,046 -9.52%
PBT -22,326 -214 -10,036 -7,801 -7,380 -6,016 1,168 -
Tax -217 -39 -29 200 -513 -350 -285 -4.43%
NP -22,109 -175 -10,007 -7,801 -7,380 -6,016 1,168 -
Tax Rate - - - - - - 24.40% -
Total Cost 24,327 13,559 10,007 7,801 7,395 6,429 2,878 42.67%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin -996.80 -1.31 0.00 0.00 -49,200.00 -1,456.66 28.87 -
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS -0.53 -0.01 -0.39 -0.55 -0.41 -0.42 0.08 -
EPS Diluted -0.53 -0.01 -0.39 -0.55 -0.41 -0.42 -0.07 40.08%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.